Damage at the cellular and organ levels in LSDs: possibility for prevention/reversibility with ERT

Affiliations

Comment

Timothy M Cox et al. Acta Paediatr Suppl. 2006 Apr.

. 2006 Apr;95(451):75-6.

doi: 10.1111/j.1651-2227.2006.tb02394.x.

¹ Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. jbg20@medschl.cam.ac.uk

No abstract available

Comment on

Lysosomal dysfunction, cellular pathology and clinical symptoms: basic principles.
Reuser AJ, Drost MR. Reuser AJ, et al. Acta Paediatr Suppl. 2006 Apr;95(451):77-82. doi: 10.1111/j.1651-2227.2006.tb02395.x. Acta Paediatr Suppl. 2006. PMID: 16720471 Review.
Inhibition and reversibility of renal changes: lessons from diabetic kidney disease.
Flyvbjerg A. Flyvbjerg A. Acta Paediatr Suppl. 2006 Apr;95(451):83-92. doi: 10.1111/j.1651-2227.2006.tb02396.x. Acta Paediatr Suppl. 2006. PMID: 16720472 Review.
Reversibility of cellular and organ pathology in enzyme replacement trials in animal models of lysosomal storage diseases.
Gieselmann V. Gieselmann V. Acta Paediatr Suppl. 2006 Apr;95(451):93-9. doi: 10.1111/j.1651-2227.2006.tb02397.x. Acta Paediatr Suppl. 2006. PMID: 16720473 Review.